Raytheon Continues Development of Counter-Hypersonic Missile for US MDA

The Glide Phase Interceptor (GPI) is designed to intercept hypersonic weapons in the glide phase of flight, providing the US and allies with an additional layer of defense against regional hypersonic missile threats. By DA Reporter / 28 Jun 2022
Raytheon Continues Developing Counter-Hypersonic Missile for US MDA

Raytheon Missiles & Defense has been selected by the US Missile Defense Agency to continue developing its first-of-its-kind counter-hypersonic missile solution.

The Glide Phase Interceptor (GPI) is designed to intercept hypersonic weapons in the glide phase of flight, providing the US and allies with an additional layer of defense against regional hypersonic missile threats. 

This firm fixed price Other Transaction Agreement (OTA) modification, valued at $41 million, increases the total value to $62 million and allows Raytheon Missiles & Defense to continue maturing its GPI design using advanced materials and technology required to intercept a hypersonic threat. This phase will also finalize systems requirements and support accelerated development timelines.

“Our GPI is built on proven missile defense technology as its foundation,” said Tay Fitzgerald, president of Strategic Missile Defense at Raytheon Missiles & Defense. “By using digital engineering and leveraging high technology readiness level components and subsystems already in use across Standard Missile and hypersonic programs, we can quickly advance the creation of this new interceptor.”

Raytheon Missiles & Defense is leveraging mature technologies from across the current portfolio to create efficiencies, reduce qualification time and demonstrate the GPI capability as quickly as possible.

Posted by DA Reporter Connect & Contact